Credit Suisse Upgrades Medtronic (MDT) to Outperform
More News related to MDT
- Highlights From MDT's Q3 Conference Call: U.S. Revenues up 5%, International Sales Up 13%; Guides Above for FY10
- Medtronic's (MDT) Earnings and Guidance Shows A Strong Heart Beat
- Medtronic (MDT) Tops Q3 Views; Guides FY10 EPS Above the Street
- Medtronic Second Quarter Revenue Increases 8% to $3.838 Billion; Raises EPS Guidance for Current Fiscal Year
- Trading Radar for 11/24: Heinz (HNZ), Dollar Tree (DLTR), Eaton Vance (EV), Hormel Foods (HRL), J. Crew (JCG) Report
More News related to Upgrades
- J. Crew (JCG) "Simply" Beats Q3 Earnings Views
- China Finance Online (JRJC) Tops Q3 EPS by 1c; Guides In-line for Q4 Revs
- TiVo (TIVO) Reports Inline Q3 Loss of $0.06; Guides Q4
- EMC (EMC) Reaffirms Q4, FY09 Non-GAAP Guidance, But Lowers GAAP Outlook
- QAD (QADI) Tops Q3 Views; Guides Q4, FY10
Credit Suisse upgrades Medtronic, Inc. (NYSE: MDT) from Neutral to Outperform.
Medtronic, Inc. develops, manufactures, and sells device-based medical therapies worldwide.
Related Categories
UpgradesStocks Mentioned
+2.94Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
